;long-acting —insulina de acción prolongada;NPH —insulina NPH;pre-mixed —insulina premezclada;rapid-acting —insulina de acción rápida;rapid-acting — analogueanálogo de insulina de acción rápida;recombinant —insulina recombinante;regular —insulina regular;to take —inyectarse insulina...
insulin glargine, lixisenatide or GLP-1 RA alone, and was associated with weight control, less hypoglycemia versus insulin glargine, and fewer GIAEsversus lixisenatide. Findings were consistent regardless of age, diabetes duration, and baseline HbA1c. The efficacy, safety, and convenient once-daily ...
The recommended starting dose of TOUJEO in insulin-naive patients with type 1 diabetes is approximately one-third to one-half of the total daily insulin dose. The remainder of the total daily insulin dose should be given as a short-acting insulin and divided between each daily meal. As a ge...
To compare steady state pharmacodynamic and pharmacokinetic profiles of insulin glargine 300 U/mL (Gla-300) with insulin degludec 100 U/mL (Deg-100) in people with type 1 diabetes. Methods This single-centre, randomized, double-blind crossover euglycaemic clamp study included two parallel cohorts...
PDB21 A COST COMPARISON OF A BASAL BOLUS REGIMEN (INSULIN GLARGINE AND INSULIN GLULISINE) WITH A CONVENTIONAL PRE-MIXED INSULIN REGIMEN IN TYPE-2 DIABETES PATIENTS – THE GINGER STUDYdoi:10.1016/j.jval.2011.02.529C.TillingandJ.Voraand